The U.S. Food and Drug Administration has called an advisory committee meeting on Sept. 17, to discuss the adverse cardiovascular outcomes with the usage of testosterone replacement therapy. http://feeds.foxnews.com/~r/foxnews/health/~3/WF3_iZzAJbM/
Read More
No comments:
Post a Comment